|
Volumn 109, Issue 2 PART 2 SUPPL., 2007, Pages 531-532
|
Alport syndrome and pregnancy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMLODIPINE;
ATENOLOL;
FUROSEMIDE;
LABETALOL;
MAGNESIUM SULFATE;
METHYLDOPA;
MISOPROSTOL;
OXYTOCIN;
ACUTE KIDNEY FAILURE;
ADULT;
ALPORT SYNDROME;
ARTERY BLOOD FLOW;
ARTICLE;
BLOOD PRESSURE;
BLURRED VISION;
CASE REPORT;
DELIVERY;
DRUG DOSE INCREASE;
DRUG SUBSTITUTION;
DYSPNEA;
ECHOGRAPHY;
EDEMA;
FATIGUE;
FEMALE;
FETUS WEIGHT;
HEART PALPITATION;
HEMODIALYSIS;
HUMAN;
HYPERKALEMIA;
HYPERTENSION;
INTRAUTERINE GROWTH RETARDATION;
KIDNEY FAILURE;
KIDNEY FUNCTION;
LABOR;
LABOR INDUCTION;
LABORATORY TEST;
LEG SWELLING;
OBESITY;
PREECLAMPSIA;
PREGNANCY;
PREGNANCY TERMINATION;
PRIORITY JOURNAL;
PROTEINURIA;
SCOTOMA;
SEIZURE;
SURVIVAL RATE;
TACHYPNEA;
UMBILICAL ARTERY;
URINALYSIS;
UTERINE ARTERY;
VASCULAR RESISTANCE;
ABORTION, THERAPEUTIC;
ADULT;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
FETAL GROWTH RETARDATION;
HUMANS;
KIDNEY FAILURE, ACUTE;
NEPHRITIS, HEREDITARY;
PRE-ECLAMPSIA;
PREGNANCY;
PREGNANCY TRIMESTER, SECOND;
PRENATAL DIAGNOSIS;
|
EID: 33846433701
PISSN: 00297844
EISSN: None
Source Type: Journal
DOI: 10.1097/01.AOG.0000240141.26395.82 Document Type: Article |
Times cited : (18)
|
References (7)
|